Article Text
Statistics from Altmetric.com
Comment
Effective antibiotic based therapies for eradicatingHelicobacter pylori have been developed in recent years.1 ,2 There is, however, an the increasing problem of antibiotic resistance in H pylori 3 and in the long term the consequence of large scale eradication programmes could be a reduction in the efficacy of current antibiotic based regimens.
The development of a vaccine against H pylori which confers long term protective immunity is the best strategy to circumvent the problem of antibiotic resistance and to eradicate H pylori on a global scale. The feasibility of inducing protective immune responses to helicobacter by oral vaccination with bacterial antigens and a mucosal adjuvant was initially demonstrated in the H felis murine model.4-6 Vaccination with both H pylori urease5 and heat shock proteins (HspA and HspB)6 protected against subsequent challenge withH felis. However, H felis lacks many of the virulence factors present inH pylori, such as thecag pathogenicity island7 and the cytotoxin VacA,8 precluding analysis of these antigens as candidate vaccines in the H felis model. The development of mouse adapted H pyloristrains which cause chronic infection in mice was a major advance.9 The H pylori mouse model has permitted the testing of vaccines containing purifiedH pylori antigens against homologous challenge infection.9 To date, a number of protectiveH pylori antigens have been identified which confer immunity against H pylori infection in …